Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 4/20 | 0.62 |
| ▸ | ACE | P12821 | 2/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8861655 | 1.00 | MME (0.62) | MMEACETAAR1SLC6A2SLC6A4 | |
| SCHEMBL8861615 | 1.00 | MME (0.62) | MMEACETAAR1SLC6A2SLC6A4 | |
| SCHEMBL8861624 | 0.93 | MME (0.62) | MMEACE | |
| SCHEMBL8693644 | 0.87 | MME (0.58) | MMEACEHPGD | |
| SCHEMBL8861700 | 0.87 | MME (0.65) | MMEACEALDH1A1LMNAHPGD | |
| SCHEMBL8861642 | 0.86 | HPGD (0.51) | MMEACEALDH1A1HPGD | |
| SCHEMBL8861625 | 0.85 | ACE (0.54) | MMEACETAAR1SLC6A2SLC6A4 | |
| SCHEMBL8861658 | 0.85 | MME (0.62) | MMEACECYP2D6LMNAHPGD | |
| SCHEMBL8861605 | 0.84 | HPGD (0.54) | MMEACEHPGD | |
| SCHEMBL3081031 | 0.84 | ACE (0.66) | MMEACETAAR1SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230301895-A1 | NAIL FORMULATIONS AND TREATMENT REGIMES | NOVABIOTICS LIMITED (GB) | 2023-09-28 | — | — | US | disclosed |